Educating Women About Benign Breast Disease
by Elizabeth Reifsnider. MSN. RNC N urses who work in community or occupational settings often are the health care professionals women use for health care education and information. Many women have not learned about their own anatomy and physiology and are uncomfortable, and possibly even fearful, about the normal cyclic changes that occur with varying hormonal levels. The occupational health nurse can be a valuable resource for women by teaching how their bodies work and how female hormones affect their breasts. Specifically, teaching breast self examination and providing information about benign breast diseases may be the most important influences a nurse can have on women's health.
ANATOMY AND PHYSIOLOGY
The breast is composed of numerous milk producing alveoli (minute sacs) that cluster into lobules. Each lobule contains 10 to 100 alveoli and is attached to a ductal which drains into a larger duct. Twenty to 40 lobules are arranged into a lobe and a breast is composed of 15 to 25 lobes. Each lobe is arranged around a duct, which drains to the nipple and has a minute opening on the nipple for milk ejection. A cluster of grapes provides an analogy that can be used when teaching breast anatomy.
The breast has extensive lymph drainage, most of it toward the axillary lymph nodes. However, the suTeaching breast self examination and providing information about benign breast diseases may be the most important influences a nurse can have on women's health. praclavicular nodes, su bclavicular nodes, and the parasternal nodes of the opposite breast may also drain the breast. The lymph drainage of the breast consists of the cutaneous area, the areola and the glandular, or deep tissue area (Bates, 1983) . The large amount of dense connective tissue between the breast lobes permits distensibility during lactation. Fibrous connective tissue bands-Cooper's ligaments-separate the lobes and attach them to the skin. The amount of subcutaneous fat determines breast size, since all women have approximately the same number of lobules (Lawrence, 1980) . The breast is a target organ for hormone activity and reacts to the monthly production of estrogen and progesterone. During each menstrual cycle, estrogen promotes the growth of the ductal tissue and progesterone promotes the growth of the glandular tissue (Lauwers, 1983) . Fluid retention in the breast during the latter half of the cycle, when progesterone is dominant, creates the fullness and soreness many women experience premenstrually.
Estrogen excess, or progesterone deficiency, is considered to playa role in the development of fibrocystic disease. Seventy percent of women who have evidence of fibrocystic disease have lowered progesterone levels (one third of normal) and irregular ovulation. The relative estrogen excess leads to edema, which can increase the breast volume up to 15% (Drukker, 1987) .
The pain accompanying fibrocystic disease is attributable to nerve irritation from edema as well as nerve pinching by fibrosis (Vorherr, 1986) . In addition, nodularity may be present because of glandular growth. For this reason, breast exams are most accurate at the end of menses when hormone production is at the lowest ebb.
FIBROCYSTIC DISEASE
Benign breast disease is a term used for a constellation of breast changes observed in premenopausal women. Fibrocystic change is used by some authors to denote the development of cysts in the breast tissue (Bartow, 1987) . Others use the term fibrocystic disease for the condition 
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FLUID-FILLED CYST of breast pain and tenderness (Drukker, 1987) . Other terms that have been used to label the fibrocystic change/disease process are mammary dysplasia and cystic mastitis.
The most common type of benign breast disease is fibrocystic disease. The occurrence rate of this condition varies from study to study. Clinically, the disease is diagnosed in 50% of women (Scott, 1986) and in 65% (Bartow, 1987) to 90% (Love, 1984) of women at autopsy. Bartow (1987) The cause of fibrocystic disease is unknown, but has been postulated to be the result of normal physiologic changes (Haagensen, 1986 ) When hormone production falls at the beginning of the menstrual cycle, the fluid accumulated in the breasts is drained by the lymphatic system.
Over time, the lymph system becomes less efficient at draining the secretions and the fluid builds up in the small glands and ducts of the breasts. The nodules formed may be small and pellet shaped, a condition known as fibroadenosis. The condition in which fluid accumulates in larger cysts in one or both breasts (see Figure) is fibrocystic disease (Birnbaum, 1980; Townsend, 1980) . Fibrocystic disease usually begins in a woman's mid 20s and lasts until menopause. It gradually worsens during the reproductive span, and in the decade before menopause women usually have the most discomfort from tender nodular breasts (Fogel, 1981) .
Women in their 20s and early 30s may experience pain 1 week premenstrually with an increase in tissue density. During their 30s, women experience nodularity (up to 1 ern), cysts (2 to 3 ern), and breast pain occurring 2 or 3 weeks premenstrually. During their 40s, women may experience permanent breast tenderness and the formation of cysts (up to 3 em) which may last until menopause (Vorherr, 1986) . With estrogen replacement therapy after menopause, breast tenderness may recur based on the dosage of estrogen prescribed.
FIBROADENOMA
Another benign breast condition, fibroadenoma, a variation of fibrocystic disease, is a painless, slow growing mass with a rubbery feel and a smooth outline. The formation of fibroadenomas may also be related to estrogen levels (Haagensen, 1986) . They vary in size from 1 to 5 em and are non-tender (Figure) . These tumors most often occur in women in their early 30s, but are the most common benign breast disease among women less then 25 years old (Haagensen, 1986) .
INTRADUCTAL PAPILLOMA AND NIPPLE DISCHARGE
Intraductal papillomas are benign tumors (2 to 3 mm) that grow in the lining of a terminal duct in the breast. They are usually within 1 em of the areola, and present as a serous or bloody nipple discharge from one duct opening on the nipple. A palpable mass can be felt approximately 50% of the time. This relatively rare condition occurs most frequently in women in their late 40s (Osuch, 1987) .
Nipple discharge can range from clear to white to green to sanguineous. Non-spontaneous nipple discharge (from vigorous breast manipulation) is not significant. Multiple or bilateral duct discharge is also of little significance, and may be related to fibrocystic disease if it is green or yellow.
A unilateral, serosanguineous nipple discharge is always significant. Sixty-five to 75% of women who present with this condition have a benign intraductal papilloma, but 10% to 50% have breast cancer (Pilnik, 1978) .
Mammary duct ectasia is a condition that occurs around the time of menopause (Hane, 1989) and is characterized by a thick, sticky nipple discharge. The epithelial lining of the breast duct breaks down, and cellular debris accumulates in the duct (Osuch, 1987) . Occasionally, inflammation will develop in the involved duct, and burning pain or itching results. Duct ectasia is not associated with cancer, but the affected duct must be biopsied since the presentation of both diseases is similar.
DIAGNOSIS
Treatment of benign breast disease is undertaken only after it is clearly differentiated from cancer. Women with fibrocystic disease may be fearful that it will lead to breast cancer. Proliferation of the epithelium of the duct increases a woman's risk of breast cancer to 1.9 times normal. If the proliferation becomes atypical hyperplasia, the risk is increased to 5.3. Atypical hyperplasia in a woman with a family history of breast cancer leads to an increased risk 11 times that of a woman who has fibrocystic disease without proliferation (DuPont, 1985) .
Proliferation and atypical hyperplasia are histologic findings and must be diagnosed by biopsy. This underscores the necessity for all women with clinically evident masses, thickening, or nipple discharge to be referred for evaluation. Twenty-five percent of biopsies obtained from women with fibrocystic disease reveal carcinoma (Vorherr, 1986) . These conditions mandate removal of a breast mass for histologic study: presence of a prominent A mammogram uses very low dose radiation and has the potential to decrease breast cancer deaths by 40% to 60%.
mass, rapid increase in tenderness or size of one breast, unexplained erythema or edema, retraction signs, spontaneous nipple discharge in a non-pregnant, non-lactating woman, and changes in the nipple (Adair, 1985) .
When a breast lump is discovered, a physician will attempt aspiration if the mass feels cystic. With fluid aspiration, many cysts will resolve. The aspirate should be examined histologically. If aspiration is unsuccessful, a biopsy must be done.
Mammography, ultrasound, and thermography are all used to evaluate a breast mass. Mammography is best at finding breast cancer in women who are over 40 because fatty tissue, more prevalent after menopause, provides the most contrast to cancerous tumors. Prior to menopause, the glandular tissue is prominent. Breast tumors originate in glandular tissue and it may be more difficult to differentiate the two.
Women with dense, glandular breasts may require mammograms more frequently and multiple views should be used. Many very small (2 mm) breast cancers produce mammographic patterns indistinguishable from benign breast disease (Potchen, 1987) . Ultrasound, thermography (a "picture" of the different temperatures of breast tissue), and physical examination, along with mammography, are more accurate in evaluating breast masses during women's reproductive years.
Ultrasound may be the best tool to evaluate fibrocystic disease because Reifsnider it can distinguish between solid masses and fluid filled cysts (Davis, 1988) . However, all dominant masses should be biopsied, since false negative mammograms do occur. A woman may have a palpable, malignant mass caused by cancer and yet have a normal mammogram (Potehen, 1987) .
TREATMENT
Dietary changes can affect fibrocystic disease. A study by Minton (1979) showed that abstaining from methylxanthines such as caffeine, theophylline, and theobromine significantly reduced fibrocystic disease, usually to the extent that lumps were no longer palpable. When methylxanthines were reintroduced to the diet, fibrocystic disease again became symptomatic.
Fibrocystic disease in younger women (35 years or younger) responded in 1 to 3 months to methylxanthine reduction. Women 45 years or more often did not become asymptomatic until they abstained from methylxanthine for 1 year (Minton, 1979) . Methylxanthines play a role in the cell growth and metabolism that result in the formation of fibrous tissue (Goldenberg, 1982) .
These studies have been challenged by later studies that failed to replicate Minton's findings. Levinson (1986) conducted a critical review of nine studies on the association of methylxanthines and fibrocystic breast disease. Three of the studies reported an association; six did not.
A controlled clinical trial (Parazzini, 1986) of 192 women failed to show any association between methylxanthine and fibrocystic breast disease. However, a study of 147 women who restricted their caffeine intake did report a reduction in breast pain (Russell, 1989) . Previous studies relied on clinical and mammographic manifestations of fibrocystic disease instead of subjective reports of breast pain as the desired result of caffeine restriction.
Given the conflicting results in the literature, it may be best for the nurse to inform clients of the possible benefit of caffeine restriction. Then the client can decide if she wants to restrict her intake of methylxanthine. The nurse should also discuss the cyclic nature of the disease. One study (Heyden, 1986 ) that examined the association of caffeine and fibrocystic disease reported fluctuations in the disease. Only 29% of the women in the premenopausal and 18% in the menopausal group had findings similar from one examination to the next during the study (Heyden, 1986) . Therefore, changes in fibrocystic breast disease that a woman may attribute to caffeine restriction could be occurring independently.
Methylxanthines are found in coffee, tea, colas, chocolate, and several respiratory and pain medications (Table) . The nurse should advise the client that beginning a "no caffeine" regimen may cause caffeine withdrawal, characterized by headaches that last for 1 or 2 days. Clients should be taught to read labels, especially of over the counter medications, since the formulations may change and caffeine may be added or removed. Herbal teas, hot broth, decaffeinated tea and coffee, and Postum (a grain-based beverage) can be consumed if the client is in the habit of drinking hot beverages. A well-fitting bra, which can be purchased at a breast prosthesis retail store, should be worn. These bras usually require individualized fitting.
Medication may be indicated if the symptoms of pain and tenderness Oral contraceptives, especially those with a low estrogen, high progestin formulation, will alter the hormonal milieu. Success rates of 70% to 90% with oral contraceptives have been reported (London, 1982) . Breast pain usually ceases with the first pill cycle, and clinical improvement is evident after 6 months (Vorherr, 1986) .
Progesterone or medroxyprogesterone acetate (Provera), without the addition of estrogen, has been prescribed. The progestin is given for 10 days during the cycle, and success rates of 80 to 85% have been obtained (Vorherr, 1986) . Some women may experience depression while taking progestins.
Danazol (Danocrine) is a synthetic androgen that inhibits the output of estrogen and progesterone. The drug usually brings about partial to complete disappearance of breast nodules and relief of the pain and tenderness. Menstrual changes may occur, but these are usually reversible within 60 to 90 days after the drug is discontinued. Danazol produces substantial side effects in 60% to 70% of women, including masculinization, hot flashes, atrophic vaginitis, hypertension, and other changes associated with menopause or an androgen excess. Danazol should not be used for women who are pregnant or breast feeding or who have abnormal vaginal bleeding.
Tamoxifen is an antiestrogen that has been used to treat fibrocystic breast disease. Side effects include hot flashes, menstrual irregularity, and nausea. It has been shown to reduce breast pain and tenderness, but not dominant cysts (Fentiman, 1987) . It is associated with fewer and milder side effects than danazol. should view their role as one of education and advocacy on behalf of the client. An occupational health nurse can teach breast self examination, either in classes or one-on-one, and raise employees' level of awareness of breast disease. Certification for teaching breast self examination is available from the American Cancer Society (ACS). ACS also provides excellent pamphlets and teaching aids. Breast models simulating different types of lumps are useful. If a woman thinks she has found a lump during breast self examination, the occupational health nurse can confirm the finding, or demonstrate that the woman is feeling a normal structure such as a rib or normal breast tissue. All women with lumps, masses, and thickenings should be referred for diagnosis. The nurse must be knowledgeable about community resources which can provide diagnosis and treatment.
Nurses also can model a healthy attitude about breast self examination, encouraging women to perform it and to discuss openly their questions and concerns. Women should be encouraged to have mammograms, following ACS guidelines: a baseline mammogram between the ages of 35 and 40, a mammogram every 1 to 2 years between the ages 40 and 49, and a yearly mammogram after age SO. The nurse may need to counter any public misinformation about the risks of mammography with the fact that a mammogram uses very low dose radiation and has the potential to decrease breast cancer deaths by 40% to 60% (Potchen, 1987) .
Occupational health nurses can work with companies and insurers to have mammograms covered by the health insurance. They also may negotiate with local providers for reduced costs and on-site screening. When nurses teach women breast self examination, educate them about their bodies, and counsel them about diet, they may contribute to significant improvement in women's health. Health promotion and dis-
